Enzyme Replacement Therapy With Taliglucerase Alfa: 36-Month Safety and Efficacy Results in Adult Pa

来源 :The 35th World Congress of the International Society of Hema | 被引量 : 0次 | 上传用户:soloviola
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Objective Taliglucerase alfa is the first approved plant cell-expressed recombinant human protein and is an enzyme replacement therapy indicated for treatment of adults with Type 1 Gaucher disease (GD).In study PB-06-002,safety and efficacy were evaluated in 26 adult patients switched from imiglucerase to taliglucerase alfa.
其他文献
Chronic neutrophilic leukemia (CNL) is a rare myeloproliferative neoplasm (MPN) characterized by sustained elevated neutrophil levels with Fewer than 20 subjects with CNL and a with T618I mutation are
会议
Aim Notch1 signaling plays a key role in the differentiation of mesenchymal stem cells (MSCs).Carfilzomib (CFZ),a second-generation proteasome inhibitor,has poten tcytotoxicity against myeloma cells.I
会议
Objective s Bone marrow angiogenesis exhibits an important role in multiple myeloma(MM),and angiogenesis often correlates with the prognosis and disease burden of MM.Our previous studies have demonstr
会议
Objective:POEMS syndrome is a rare plasma cell dyscrasia and vascular endothelial growth factor (VEGF),a cytokine correlates with disease activity,is used for disease monitoring.Although clinical impr
会议
Aim Hereditary factor XI deficiency (FXID) is an autosomal inherited coagulation disorder characterized by mild bleeding disorder mainly associated with injury or surgery,which is related to a variety
会议
Objective:However methotrexate has a remarkable therapeutic effect in childhood ALL,some patients under treatment of this drug manifest complications in various organs.The aim of this study was to eva
会议
Objective:Genetic characteristics is now considered a standard of care for multiple myeloma (MM) at the time of original diagnosis.Interphase fluorescence in situ hybridization (FISH) has emerged as t
会议
Objective:Taliglucerase alfa is a β-glucosidase enzyme replacement therapy approved in the USA and other countries for treatment of Gaucher disease (GD) in adults,and the first approved plant cell-exp
会议
Introduction congenital FXIII deficiency is a rare bleeding disorder with a high risk of spontaneous intracranial haemorrhage.Life-long preventive supplementation is mandatory if FXIII activity is Aim
会议
Bachground and Objective s Hemophagocytic lymphohistiocytosis (HLH) patients presented a specific cytokine pattern consisting of significantly elevated interferon-gamma (IFN-γ) and interleukin (IL)-10
会议